These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Acvr1b Loss Increases Formation of Pancreatic Precancerous Lesions From Acinar and Ductal Cells of Origin. Saeki K; Wood IS; Wang WCK; Patil S; Sun Y; Schaeffer DF; Su GH; Kopp JL Cell Mol Gastroenterol Hepatol; 2024; 18(5):101387. PubMed ID: 39111635 [TBL] [Abstract][Full Text] [Related]
8. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice. He P; Yang JW; Yang VW; Bialkowska AB Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441 [TBL] [Abstract][Full Text] [Related]
9. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma. Lee AYL; Dubois CL; Sarai K; Zarei S; Schaeffer DF; Sander M; Kopp JL Gut; 2019 Mar; 68(3):487-498. PubMed ID: 29363536 [TBL] [Abstract][Full Text] [Related]
10. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16. Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115 [TBL] [Abstract][Full Text] [Related]
11. mTORC1 and mTORC2 Converge on the Arp2/3 Complex to Promote Kras Zhao Y; Schoeps B; Yao D; Zhang Z; Schuck K; Tissen V; Jäger C; Schlitter AM; van der Kammen R; Ludwig C; D'Haese JG; Raulefs S; Maeritz N; Shen S; Zou X; Krüger A; Kleeff J; Michalski CW; Friess H; Innocenti M; Kong B Gastroenterology; 2021 Apr; 160(5):1755-1770.e17. PubMed ID: 33388318 [TBL] [Abstract][Full Text] [Related]
12. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice. Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet. Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001 [TBL] [Abstract][Full Text] [Related]
14. Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis. Tamura K; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Ideno N; Aso T; Miyazaki T; Ohuchida K; Takahata S; Ito T; Ushijima Y; Oda Y; Mizumoto K; Tanaka M Surgery; 2015 Feb; 157(2):277-84. PubMed ID: 25530484 [TBL] [Abstract][Full Text] [Related]
15. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. Amato E; Molin MD; Mafficini A; Yu J; Malleo G; Rusev B; Fassan M; Antonello D; Sadakari Y; Castelli P; Zamboni G; Maitra A; Salvia R; Hruban RH; Bassi C; Capelli P; Lawlor RT; Goggins M; Scarpa A J Pathol; 2014 Jul; 233(3):217-27. PubMed ID: 24604757 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma. Ideno N; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Aso T; Aishima S; Miyasaka Y; Ohuchida K; Ueda J; Takahata S; Oda Y; Mizumoto K; Tanaka M Pancreas; 2015 Mar; 44(2):311-20. PubMed ID: 25479586 [TBL] [Abstract][Full Text] [Related]
17. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm. Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060 [TBL] [Abstract][Full Text] [Related]
18. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms. Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224 [TBL] [Abstract][Full Text] [Related]
19. Identification and manipulation of biliary metaplasia in pancreatic tumors. Delgiorno KE; Hall JC; Takeuchi KK; Pan FC; Halbrook CJ; Washington MK; Olive KP; Spence JR; Sipos B; Wright CV; Wells JM; Crawford HC Gastroenterology; 2014 Jan; 146(1):233-44.e5. PubMed ID: 23999170 [TBL] [Abstract][Full Text] [Related]
20. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Siveke JT; Einwächter H; Sipos B; Lubeseder-Martellato C; Klöppel G; Schmid RM Cancer Cell; 2007 Sep; 12(3):266-79. PubMed ID: 17785207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]